CVS HEALTH Corp (NYSE: CVS)

Sector: Healthcare Industry: Healthcare Plans CIK: 0000064803
Market Cap 101.72 Bn
P/B 1.59
P/E 15.33
P/S 0.40
ROIC (Qtr) 6.44
Div Yield % 3.41
Rev 1y % (Qtr) 8.17
Total Debt (Qtr) 79.95 Bn
Debt/Equity (Qtr) 1.06
Add ratio to table...

About

CVS Health Corporation, commonly known as CVS Health, is a prominent player in the health care industry, operating under the ticker symbol CVS. The company's primary business activities encompass providing health care benefits, health services, and pharmacy services to its customers. With a vast network of over 9,000 retail locations, more than 1,000 walk-in medical clinics, and a leading pharmacy benefits manager, CVS Health has established a significant presence in the health care landscape. The company's revenue is derived from multiple segments,...

Read more

Investment thesis

Bull case

  • Robust free cash flow of 7.81B exceeds capital expenditure of 2.83B by 2.76x, indicating strong organic growth funding capability.
  • Retained earnings of 61.20B represent substantial 0.81x of equity 75.21B, indicating strong internal capital generation.
  • Cash reserves of 8.45B provide comfortable 2.21x coverage of tax obligations 3.83B, showing strong fiscal management.
  • Operating cash flow of 10.64B provides strong 3.76x coverage of capital expenditure 2.83B, enabling organic growth.
  • Free cash flow of 7.81B provides solid 1.36x coverage of operating expenses 5.72B, showing operational efficiency.

Bear case

  • Operating cash flow of 10.64B barely covers its investment activities of (5.87B), with a coverage ratio of -1.81, indicating heavy reliance on external financing for growth which may not be sustainable in a tighter credit environment.
  • Operating cash flow of 10.64B provides thin coverage of dividend payments of (3.40B) with a -3.13 ratio, suggesting potential dividend sustainability issues if operational performance deteriorates.
  • Cash reserves of 8.45B provide limited coverage of acquisition spending of (436M), which is -19.39x, suggesting aggressive expansion might strain liquidity if market conditions deteriorate.
  • High receivables of 39.78B relative to inventory of 19.25B (2.07 ratio) suggests aggressive credit terms or collection difficulties, potentially masking revenue quality issues.
  • Long-term investments of 32.67B represent a high 1.16x of fixed assets 28.06B, indicating potential overexposure to financial assets versus operational capabilities.

Segments Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer comparison

Companies in the Healthcare Plans
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 UNH Unitedhealth Group Inc 275.49 Bn 47.39 1.75 80.14 Bn
2 CVS CVS HEALTH Corp 101.72 Bn 15.33 0.40 79.95 Bn
3 CI Cigna Group 85.42 Bn 23.60 0.41 34.04 Bn
4 ELV Elevance Health, Inc. 77.22 Bn 13.64 0.39 32.05 Bn
5 HUM Humana Inc 25.29 Bn 14.38 0.43 12.92 Bn
6 CNC Centene Corp 20.34 Bn -3.05 0.10 17.40 Bn
7 MOH Molina Healthcare, Inc. 7.17 Bn 15.19 0.16 3.95 Bn
8 ALHC Alignment Healthcare, Inc. 3.90 Bn -187.18 1.07 0.33 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 0.73 1.08
EV to Cash from Ops. EV/CFO 14.49 3.83
EV to Debt EV to Debt 2.33 9.18
EV to EBIT EV/EBIT 15.47 -1,594.13
EV to EBITDA EV/EBITDA 11.38 15.88
EV to Free Cash Flow [EV/FCF] EV/FCF 17.92 8.41
EV to Market Cap EV to Market Cap 1.83 1.08
EV to Revenue EV/Rev 0.73 0.68
Price to Book Value [P/B] P/B 1.59 4.79
Price to Earnings [P/E] P/E 15.33 -5.08
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Div Coverage (Qtr) 0.52 1.21
Dividend Payout Ratio % Div Payout % (Qtr) 190.00 29.17
Dividend per Basic Share Div per Share (Qtr) 2.66 2.51
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 43.17 16.79
Interest Coverage Int. cover (Qtr) 1.70 -0.47
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) -1.83 -30.05
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) -1.55 18.06
Dividend Growth (1y) % Div 1y % (Qtr) 0.00 2.04
EBIAT Growth (1y) % EBIAT 1y % (Qtr) -36.95 -108.29
EBITDA Growth (1y) % EBITDA 1y % (Qtr) -45.28 -60.87
EBIT Growth (1y) % EBIT 1y % (Qtr) -42.03 -84.20
EBT Growth (1y) % EBT 1y % (Qtr) -64.77 -142.02
EPS Growth (1y) % EPS 1y % (Qtr) -61.85 -164.11
FCF Growth (1y) % FCF 1y % (Qtr) 23.41 111.09
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) 7.71 7.06
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 1.59 2.20
Cash Payout Ratio Cash Payout (Qtr) 0.25 0.11
Cash Ratio Cash Ratio (Qtr) 0.10 0.48
Current Ratio Curr Ratio (Qtr) 0.84 1.46
Debt to Equity Ratio Debt/Equity (Qtr) 1.06 0.77
Interest Cover Ratio Int Coverage (Qtr) 1.70 -0.47
Times Interest Earned Times Interest Earned (Qtr) 1.70 -0.47
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) 1.30 1.97
EBIT Margin % EBIT Margin % (Qtr) 1.32 1.42
EBT Margin % EBT Margin % (Qtr) 0.54 0.98
Gross Margin % Gross Margin % (Qtr) 13.80 14.54
Net Profit Margin % Net Margin % (Qtr) 0.40 0.45